Loading the section…
The price of RxSight, Inc. (RXST) on October 9, 2026 is 4.81 USD, -0.82% on the day. Over 52 weeks the stock traded between 4.48 USD and 13.22 USD; the price now sits 4% of the way up that range. Over the past year the price changed by -41.41%. Market capitalization is 199.06 million USD, rank 6 among 7 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 4 November 2026 · Earnings calendar
Change over the period shown (line colour): −36.42 %
RxSight, Inc. trades on Nasdaq under the ticker RXST. The company belongs to the Health care sector. The trading history on this page starts on 30 July 2021.
Over the past 52 weeks RXST has traded between 4.48 $ and 13.22 $. As of 9 October 2026 the price stood 3.78 % of the way from the 52-week low to the high.
Over one year RXST shares fell 41.41 %; over six months they fell 29.58 %. Volatility over 90 days is 59.97 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 1.6, below the sector median of 4.0. Price to book is 0.7, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 4.83 | 4.94 | 4.75 | 4.81 | 521,900 |
| 8 October 2026 | 4.74 | 4.86 | 4.68 | 4.85 | 938,300 |
| 7 October 2026 | 4.61 | 4.95 | 4.61 | 4.80 | 842,200 |
| 6 October 2026 | 4.76 | 4.76 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:100 COLUMBIA STREET SUITE 120, ALISO VIEJO, CA, 92656, US
RxSight, Inc. reported revenue of 127M $ and a net loss of 47M $ over the last four quarters. Net margin is −36.59 %. Revenue changed by −14.05 % year over year. Earnings per share are −1.13 $. Market capitalisation is 199M $.
RXST has a return on equity of −17.45 %, above the sector median of −41.68 %. Return on assets is −15.34 %, above the sector median of −32.11 %. Operating margin is −43.42 %, below the sector median of −26.84 %.
| 37M |
| STAASTAAR Surgical Company | 21.67 | −3.17 % | 22M |
| BLCOBausch + Lomb Corporation | 17.30 | +0.87 % | 6M |
| LUCYInnovative Eyewear, Inc. | 0.9030 | +0.67 % | 219,979 |
| MRNAModerna, Inc. | 225.00 | +14.21 % | 3.0B |
| 4.60 |
| 4.65 |
| 623,000 |
| 5 October 2026 | 4.70 | 4.81 | 4.62 | 4.76 | 483,800 |
| 2 October 2026 | 4.75 | 4.77 | 4.63 | 4.68 | 616,700 |
| 1 October 2026 | 4.88 | 4.89 | 4.74 | 4.75 | 508,900 |
| 30 September 2026 | 4.80 | 4.99 | 4.67 | 4.90 | 705,700 |
| 29 September 2026 | 4.67 | 4.78 | 4.62 | 4.77 | 810,900 |
| 28 September 2026 | 4.67 | 4.78 | 4.61 | 4.67 | 1M |
| 25 September 2026 | 4.72 | 4.78 | 4.63 | 4.66 | 1M |
| 24 September 2026 | 4.85 | 4.91 | 4.67 | 4.73 | 1M |
| 23 September 2026 | 4.90 | 4.99 | 4.84 | 4.85 | 593,400 |
| 22 September 2026 | 5.05 | 5.16 | 4.90 | 4.93 | 848,800 |
| 21 September 2026 | 5.21 | 5.34 | 5.05 | 5.14 | 627,700 |
| 18 September 2026 | 5.25 | 5.36 | 5.17 | 5.20 | 1M |
| 17 September 2026 | 5.58 | 5.58 | 5.17 | 5.32 | 1M |
| 16 September 2026 | 5.56 | 5.58 | 5.31 | 5.40 | 803,000 |
| 15 September 2026 | 6.05 | 6.05 | 5.60 | 5.62 | 679,200 |
| 14 September 2026 | 6.02 | 6.21 | 5.96 | 6.11 | 632,100 |